News Home

Is Roivant Sciences (ROIVW) a Winner in the Healthcare Sector?

Wednesday, June 28, 2023 03:54 PM | InvestorsObserver Analysts
Is Roivant Sciences (ROIVW) a Winner in the Healthcare Sector?

Roivant Sciences (ROIVW) is around the top of the Healthcare sector according to InvestorsObserver. ROIVW received an overall rating of 78, which means that it scores higher than 78% of stocks. Additionally, Roivant Sciences scored a 71 in the Healthcare sector, ranking it higher than 71% of stocks in that sector.

Overall Score - 78
ROIVW has an Overall Score of 78. Find out what this means to you and get the rest of the rankings on ROIVW!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 78 means the stock is more attractive than 78 percent of stocks. Not only are these scores easy to understand, but it is easy to compare stocks to each other. You can find the best stock in healthcare or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Roivant Sciences Stock Today?

Roivant Sciences (ROIVW) stock is trading at $2.46 as of 3:44 PM on Wednesday, Jun 28, a gain of $0.39, or 18.84% from the previous closing price of $2.07. The stock has traded between $2.14 and $2.52 so far today. Volume today is more active than usual. So far 323,822 shares have traded compared to average volume of 89,587 shares. Click Here to get the full Stock Report for Roivant Sciences stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App